We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis

By MedImaging International staff writers
Posted on 12 Jun 2026
Image: Screening mammograms and artificial intelligence (AI) score changes over time in two individuals with screen-detected cancer. Full-field digital mammograms show craniocaudal (top) and mediolateral (bottom) views of the left and right breast (Photo courtesy of Radiological Society of North America)
Image: Screening mammograms and artificial intelligence (AI) score changes over time in two individuals with screen-detected cancer. Full-field digital mammograms show craniocaudal (top) and mediolateral (bottom) views of the left and right breast (Photo courtesy of Radiological Society of North America)

Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead to more intensive treatment and poorer outcomes for patients and health systems. To help address this challenge, researchers evaluated whether commercially available radiology artificial intelligence (AI) can identify early warning signals in standard screening images and provide advance alerts of future breast cancer.

The investigation assessed three commercially available radiology AI-based computer‑assisted detection systems (AI‑CAD) on mammograms from the Validation of Artificial Intelligence for Breast Imaging (VAI‑B) database. The research team at Karolinska University Hospital in Stockholm conducted a retrospective analysis spanning January 2008 to April 2019. The dataset comprised 88,963 mammograms from 31,394 individuals across four regions of Sweden. In the national screening program, women aged 40 to 74 are invited for examinations every two years, and each mammogram is traditionally double‑read by two radiologists.

Each AI‑CAD system generated a cancer prediction score from prior mammograms. On average, scores were elevated among individuals who were later diagnosed with breast cancer and remained low among those who stayed cancer‑free. Approximately 20% of breast cancer cases demonstrated mammographic signs that were already visible to AI around six years before diagnosis.

When performance was set to 90% specificity, the systems identified early signs at progressively higher rates as the diagnosis approached. They flagged up to 19.7% of individuals six years before recorded diagnosis, up to 25.2% four years before, and up to 39.3% two years before. Across the study period, radiologist readers diagnosed cancer in 12,072 participants, representing 38.5% of the cohort.

The authors note that AI‑CAD scores could support radiologists in spotting nascent mammographic changes and, with a personalized interpretation of score trajectories, help determine who might benefit from closer vigilance. The study was published in Radiology, a journal of the Radiological Society of North America (RSNA), under the title “Artificial Intelligence Detection Scores in Screening Mammography for Early Breast Cancer Alerts.” The findings add to evidence that AI may complement established double‑reading workflows within organized screening programs.

Related Links
Karolinska University Hospital
RSNA

Half Apron
Demi
Digital Color Doppler Ultrasound System
MS22Plus
Mammo DR Retrofit Solution
DR Retrofit Mammography
Medical Radiographic X-Ray Machine
TR30N HF

Channels

General/Advanced Imaging

view channel
Image: The study developed a marker based on the analysis of routine CT scans of gastric cancer patients treated at UNICAMP. Higher radiodensity values for adipose tissue are linked to a worse prognosis. In contrast, higher values for muscle are linked to a more favorable outcome (Photo courtesy of FCM-UNICAMP)

CT-Derived Biomarker Predicts Outcomes in Gastric Cancer

Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.